Evidence map›Paper›PMID 34884873›Full record

ArticleInternational journal of molecular sciences2021

Sustainable Stabilizer-Free Nanoparticle Formulations of Valsartan Using Eudragit

Eszter Hajba-Horváth, Andrea Fodor-Kardos, Nishant Shah, Matthias G Wacker, Tivadar Feczkó

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. RSC advances · 2022
    Article
  3. Factors Determining Plasticity of Responses to Drugs.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Eszter Hajba-HorváthFaculty of Engineering, Research Institute of Biomolecular and Chemical Engineering, University of Pannonia, Egyetem u. 10, H-8200 Veszprém, Hungary.
Andrea Fodor-KardosFaculty of Engineering, Research Institute of Biomolecular and Chemical Engineering, University of Pannonia, Egyetem u. 10, H-8200 Veszprém, Hungary.ORCID 0000-0002-8575-8931
Nishant ShahCollege of Pharmacy, University of Michigan, 500 S State Street, Ann Arbor, MI 48109, USA.ORCID 0000-0003-3388-2209
Matthias G WackerDepartment of Pharmacy, National University of Singapore, 4 Science Drive 2, Singapore 117544, Singapore.ORCID 0000-0002-2789-6463
Tivadar FeczkóFaculty of Engineering, Research Institute of Biomolecular and Chemical Engineering, University of Pannonia, Egyetem u. 10, H-8200 Veszprém, Hungary.
University of Pannonia · HUNational University of Singapore · SGState Street (United States) · US

Funding

National University of Singapore R-148-000-282-133
6 · The paper itself

Abstract

The bioavailability of the antihypertensive drug valsartan can be enhanced by various microencapsulation methods. In the present investigation, valsartan-loaded polymeric nanoparticles were manufactured from Eudragit

Indexed as

Antihypertensive AgentsDrug Delivery SystemsDrug LiberationExcipientsGastric JuiceHumansNanoparticlesParticle SizePolymethacrylic AcidsPolyvinyl AlcoholValsartanAntihypertensive AgentsExcipientsmethylmethacrylate-methacrylic acid copolymerPolymethacrylic AcidsPolyvinyl AlcoholValsartandrug releaseemulsion-solvent evaporationEudragit®in silico modelingnanoparticles for drug deliveryvalsartan

Identifiers

PMID34884873
PMCPMC8657980
OpenAlexW3217196321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.